H
ypertension is a significant risk factor for many cardiovascular, cerebrovascular, and renal diseases that affects approximately one in four Americans across all major ethnic groups. 1 Hypertensionassociated diseases constitute a major public health burden. Although genetic mutations have been identified for rare forms of hypertension such as Liddle's syndrome, 2 multiple etiologies involving interactions among genes and environments complicate the genetic dissection of more prevalent forms of hypertension. The impact of hypertension varies among ethnic groups. It is more prevalent, strikes earlier, and is associated with more severe complications in African Americans than in any other ethnic group. Therefore, identification of genes with pronounced effects that contribute to the risk of hypertension constitutes a priority, as this may enable early identification of individuals at high risk, development of more efficacious treatments tailored for patients, and targeted prevention strategies.
Because so many intermediate pathways contribute to interindividual variability in blood pressure (BP) and hypertension, variations in a large number of genes potentially influence these complex traits. Therefore, the detectable impact of any one gene is probably subdued as its effect is likely transmitted across many intervening pathways, thus complicating their detection. Genome-wide investigations constitute an important approach to gene finding for common chronic diseases. Here we present the results from one large-scale genome-wide linkage study called the HyperGEN Network.
Methods

Study Population
The Hypertension Genetic Epidemiology Network (HyperGEN) is a constituent multicenter Network participating in the National Heart, Lung and Blood Institute (NHLBI) Family Blood Pressure Program (FBPP). HyperGEN recruited two types of participants (hypertensive sibships and random samples of subjects) in African Americans and whites. Recruitment of the study participants, including the hypertensive probands, was carried out at five field centers (FC) based largely on ongoing population-based studies. 3 The study protocols and the process for obtaining informed consent were approved by the Institutional Review Committees at the FC. 3 In all, HyperGEN recruited and characterized a total of 1142 white hypertensive subjects from 480 sibships, yielding a total of 992 self-reported sibpairs, and a random sample of 472 biologically unrelated white participants. Likewise, it recruited and characterized a total of 1261 African American hypertensive subjects from 596 sibships yielding a total of 826 self-reported sibpairs, and a random sample of 446 biologically unrelated African Americans. This report is based on the entire sample. Overall, the study was designed to have 80% power or better under ideal conditions to detect linkage as long as the trait locus accounts for at least one-third of the affected individuals.
All the samples described, involving a total of 992 ϩ 826 ϭ 1818 sibpairs, have been characterized fully for a variety of phenotypes 3 including hypertension. Genotyping has been carried out on all the hypertensive sibs and a subset of the random samples (213 whites and 231 African Americans). The random samples are used to estimate ethnicity-specific allele frequencies for the purpose of estimating allele sharing identical-by-descent (IBD) by a sibpair. In recruiting hypertensive sibs, persons with hypertension diagnosed after 60 years of age and those with type I diabetes were excluded. Type II diabetics were not excluded.
Diagnostic Algorithm
HyperGEN was designed to increase statistical power by recruiting sibships preferentially with severe hypertensives (those with stage 2 or higher of the Sixth Report of the Joint National Committee classification, namely systolic BP Ն160 or diastolic BP Ն100 mm Hg; or the use of two or more antihypertensive medications). Nearly 80% of the sibships in each race group are severe, and the remaining are mild sibships.
Genotyping
Genome-wide scan was performed by the Mammalian Genotyping Service (MGS) in Marshfield using a standard panel of approximately 391 anonymous markers. Using the marker data, we have performed extensive quality checks for parentage errors and misinheritance, and created cleaned datasets before carrying out the genome-wide linkage analysis. The cleaned dataset included a total of 1565 sibpairs.
Genetic Analysis
Using the cleaned datasets, genome-wide multipoint linkage analysis of the hypertension phenotype was performed using MAPMAKER/SIBS. 4 All possible sibpairs were used without any weighting. Marker order and map locations were deduced from the Marshfield map. Linkage evidence is expressed in terms of likelihood scores (LOD).
Results
The results from multipoint linkage analyses are presented as LOD score plots (http://www.biostat.wustl.edu/ hypergen/results.html). This analysis yielded only one interesting region with a LOD score Ͼ1.5, which was located at 63 cM from the p telomere on chromosome 2 in the African American sibpairs (a maximum LOD score of 2.08). The evidence on chromosome 2 was decidedly lacking in the whites (with a maximum LOD score of only 0.24 at that location).
Assuming that severity (severe-severe sibpairs) or early age at diagnosis of hypertension (by age 55 years) would enhance any true signal, we carried out analyses of those groups. The primary finding on chromosome 2p shows consistency across groups, although none lead to a dramatic increase in the LOD score (see Fig. 2 on the web site). The group of severe sibships lead to a slight improvement in the maximum LOD score (from 2.08 to 2.26). Table 1 summarizes all LOD scores Ͼ1.0 by group, chromosome, and ethnicity, which shows a few more potentially interesting genomic regions in specific groups.
Discussion
As reported here, a genome-wide linkage scan with 1565 hypertensive (affected) sibpairs (650 African American and 915 white) has produced only one potentially interesting finding on chromosome 2p (at 63 cM from p telomere with a maximum LOD score of 2.08 in the African American sample, with little evidence in the white sample), which reflects the general difficulty in finding genes for complex diseases like hypertension. The lack of consistency of evidence between the two ethnic groups should not be construed as indicative of different genes predisposing the two ethnic groups to hypertension. It is possible that the latent hypertension genes have the same or similar function in both ethnic groups, with perhaps different gene frequencies, so that the at-risk allele for a given gene is less prevalent in one ethnic group than the other. Alternatively, it is possible that there are important determinants (either genetic or environmental) that interact with the predisposing genes in different ways in the two populations. It is conceivable that the genes express themselves only in interaction with at-risk lifestyles that may be more prevalent in one ethnic group.
Numerous other studies have sought to identify genes for hypertension and BP. Four previous genome-wide scans are particularly noteworthy for the sampling designs used, or for the relatively large sample sizes, or for consistency with our primary finding here. Krushkal et al 5 have reported a genome-wide scan for systolic BP using highly discordant white sibpairs and identified four genomic regions of potential interest (on 2p, 5q, 6q, and 15q). Xu et al 6 have reported the results of a genome-wide scan for BP using a very large sample of Chinese sibpairs, with five informative findings on chromosomes 3, 11, 15, 16, and 17. A genome-wide linkage scan of the Quebec Family Study 7 also found a quantitative trait locus (QTL) for systolic BP on chromosome 2p (97 cM) with a LOD score of 2.28. Atwood et al 8 also found a QTL at this same marker in the San Antonio Heart Study. This makes our finding on 2p more interesting, although these findings span a broad region on 2p. However, in multipoint genome-wide analyses, it is important to remember that such findings are quite sensitive to the exact genetic map used for IBD computations, potentially leading to shifts in the regions inferred.
These results may provide a basis for identifying the underlying trait genes. The DNA sequence variants in the candidate genes and expressed sequence tags in these regions are candidates for contributing to hypertension risk, and possibly to interindividual variation in BP. HyperGEN is currently pursuing candidate genes in the 2p region identified. Identification of the exact functional mutations may suggest novel mechanisms for BP regulation and the development of hypertension that could suggest new therapies.
On the face of etiologic heterogeneity, analysis of appropriate groups can enhance gene finding. Strategies that enable investigators to sort families into relatively more homogeneous groups are extremely desirable. Pooling data from multiple studies can provide large sample sizes necessary for splitting the aggregate data, in turn, into multiple relatively homogeneous groups. We believe that such a lumping and splitting strategy 9 is a reasonable one that is, in general, capable of enhancing gene finding. 
